Epify

Description: Epify develops epigenetic biomarkers for early cancer detection & personalized oncology, improving patient prognosis. Founded in 2019.

Country: Netherlands

Based in: Maastricht

Founded: 2019

Funding Stage: Seed

Tags: ['Biotechnology', 'Health Care', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.